Pages that link to "Item:Q5122852"
From MaRDI portal
The following pages link to Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations (Q5122852):
Displaying 13 items.
- A comparison of methods for constructing confidence intervals after phase II/III clinical trials (Q2874297) (← links)
- SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION (Q5066789) (← links)
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts (Q5122851) (← links)
- How Practical are Adaptive Designs Likely to be for Confirmatory Trials? (Q5122853) (← links)
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Opportunities and Limitations (Q5122854) (← links)
- Blinded sample size recalculation in adaptive enrichment designs (Q6550297) (← links)
- Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments (Q6572271) (← links)
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs (Q6618333) (← links)
- Adding experimental treatment arms to multi-arm multi-stage platform trials in progress (Q6618355) (← links)
- A conditional error function approach for adaptive enrichment designs with continuous endpoints (Q6624677) (← links)
- Point estimation for adaptive trial designs. II: Practical considerations and guidance (Q6625791) (← links)
- Seamless phase 2/3 oncology trial design with flexible sample size determination (Q6627434) (← links)
- Adaptive enrichment trials: what are the benefits? (Q6627920) (← links)
